STOCK TITAN

Rosalind Advisors/Fund report 9.9% in PolyPid (PYPD) via warrants and shares

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

PolyPid Ltd. filed an amendment to its Schedule 13G/A disclosing that Rosalind Advisors Inc., Rosalind Master Fund L.P., Steven Salamon and Gilad Aharon each report shared beneficial voting and dispositive power over 5,384,813 shares, representing 9.9% of the class based on 18,204,002 ordinary shares outstanding as of December 31, 2025.

The filing states 597,926 shares are directly held and an additional 4,786,887 shares are issuable upon exercise of warrants subject to a blocker that prevents exercise to the extent it would increase beneficial ownership above 9.99%. The advisor and named individuals disclaim beneficial ownership beyond their advisory roles.

Positive

  • None.

Negative

  • None.

Insights

Holds sizeable reported position capped by warrant "blocker" at 9.99%.

The Schedule 13G/A shows shared voting and dispositive power over 5,384,813 shares (listed as 9.9%) calculated against 18,204,002 outstanding shares as of December 31, 2025. The filing separately lists 597,926 held shares and 4,786,887 warrants exercisable subject to a blocker.

The blocker clause is explicit in the filing; it limits immediate conversion/exercise and constrains near-term dilution from the warrants. Subsequent filings would be required to show any change in exercised warrants or ownership percentages.

Reported shared power 5,384,813 shares shared voting and dispositive power reported for each reporting person
Percent of class 9.9% percentage based on 18,204,002 outstanding shares as of December 31, 2025
Shares outstanding (anchor) 18,204,002 shares ordinary shares outstanding as of December 31, 2025
Directly held shares 597,926 shares shares of Common Stock directly reported as held
Warrants issuable 4,786,887 shares shares issuable upon exercise of warrants subject to a blocker
blocker regulatory
"contain a blocker provision under which the holder thereof does not have the right to exercise any of the warrant"
beneficial ownership financial
"may be deemed to have the beneficial ownership of 597,926 shares of common stock"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared dispositive power regulatory
"Shared Dispositive Power 5,384,813.00"
Schedule 13G/A regulatory
"filed an amendment to its Schedule 13G/A disclosing"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.





M8001Q126

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: This percentage is calculated based upon 18,204,002 Ordinary shares of the Issuers common stock outstanding as of December 31, 2025, based on the press release issued by Polypid Ltd on February 11, 2026, titled "Polypid Provides Corporate update and reports fourth quarter and full-year 2025 financial results". However, as more fully described in Item 4, the securities reported in rows 6, 8 and 9 show the number of shares of Common Stock that would be issuable upon full conversion and exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows 6, 8 and 9. (6) 597,926 shares of Common Stock 4,786,887 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 597,926 shares of Common Stock 4,786,887 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 597,926 shares of Common Stock 4,786,887 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 597,926 shares of Common Stock 4,786,887 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G



Rosalind Advisors, Inc.
Signature:Steven Salamon
Name/Title:President
Date:05/12/2026
SALAMON STEVEN A J
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:05/12/2026
Aharon Gil
Signature:Gil Aharon
Name/Title:Gil Aharon
Date:05/12/2026
Rosalind Master Fund L.P.
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:05/12/2026

FAQ

What stake does Rosalind Advisors report in PolyPid (PYPD)?

They report shared power over 5,384,813 shares, equal to 9.9% of the class based on 18,204,002 outstanding as of December 31, 2025. The filing attributes 597,926 directly held shares and 4,786,887 warrant shares subject to a blocker.

How many shares are directly held versus exercisable by warrants?

The filing lists 597,926 shares of Common Stock directly held and 4,786,887 shares issuable upon exercise of warrants, with warrant exercises limited by a 9.99% blocker.

What is the "blocker" described in the filing?

The blocker prevents exercising warrants to the extent that exercise would result in beneficial ownership above 9.99%. As stated, the reporting persons were unable to exercise warrants due to this blocker at the filing date.

Do the advisors and managers claim beneficial ownership of the shares?

The filing states Rosalind Advisors is the investment advisor to the fund and Mr. Salamon and Mr. Aharon are portfolio managers; each may be deemed to have beneficial ownership of shares held by the fund, but they disclaim beneficial ownership as described in the filing.

What baseline share count is used to calculate the percentage ownership?

The percentage calculations use 18,204,002 ordinary shares outstanding as of December 31, 2025, per the issuer press release cited in the filing.